Cardiovascular / Cardiology News From Medical News Today
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Looking for a medical communications company? MedWrite International specializes in delivering global strategic medical marketing communications. Visit MedWrite's site to learn more.
This page shows you the latest items in this publication.
3761 records returned
Positive Results From Chronic Study With Bayer's Rivaroxaban Will Be Presented As A Late Breaker At ASH 2009
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Findings from the Phase III EINSTEIN-Extension study will be presented in the Late Breaking Abstract Session on December 8, 2009, (7:30 am EST, Hall F, Ernest N. Morial Convention Center) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 21, 2009 Category: Cardiology Tags: Vascular Source Type: news
Cardiovascular Systems Enrolls First Patient In CALCIUM 360 Degree Clinical TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cardiovascular Systems, Inc. (CSI) (Nasdaq:CSII), announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company's 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI's Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg. The first procedure was performed successfully by Dr. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 20, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
VerifyNow(R) System Highlighted In POPular Study Comparing Platelet Reactivity TestsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in the POPular study, which was presented during a Late Breaking Clinical Trials session at the American Heart Association's annual Scientific Sessions. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 20, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Results Presented From First Study Reviewing Convergent Approach To Treating Atrial Fibrillation At American Heart Association Scientific SessionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF). (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 20, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Miller School Researchers Present Findings At AHA Scientific SessionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A multidisciplinary team of clinical and basic science researchers in the Vascular Biology Institute at the University of Miami Miller School of Medicine has discovered a possible molecular signature of coronary artery disease in bone marrow stem cells. The dramatic findings were presented on November 16 at the American Heart Association's Scientific Sessions in Orlando. Coronary artery disease remains the number one killer in the United States and much of the Western world. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 20, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Clinical Data, Inc. Initiates Phase III Trial Of Stedivaze For Cardiac Stress TestingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Data, Inc. (NASDAQ: CLDA) announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze™, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze (apadenoson) for use as a pharmacologic stress agent in myocardial perfusion imaging (MPI), a method for detecting defects in the blood supply to the heart. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 20, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Telephone-Delivered Care For Treating Depression After Coronary Artery Bypass Graft Surgery Appears To Improve OutcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 20, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Study Supports Use Of MTWA Test As Predictor Of Sudden Cardiac DeathEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cambridge Heart, Inc. (OTCBB-CAMH), announced that results of the PREVENT-SCD trial, presented at the American Heart Association Scientific Sessions in Orlando, Florida, reinforce the value of the Microvolt T-wave Alternans (MTWA) test in identifying patients at risk of sudden cardiac death (SCD). (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
PanGenex Expands Clinical Trial Sites After Promising Pre-Clinical Data About Lower Coronary Arterial Calcium Scores In Cardiac PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PanGenex Corporation (Pink Sheets: PGCX) ("PanGenex" or "the Company") announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
People With Type D Personalities Experience More Health ProblemsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
People who experience a lot of negative emotions and do not express these experience more health problems, says Dutch researcher Aline Pelle. She discovered that heart failure patients with a negative outlook reported their complaints to a physician or nurse far less often. The personality of the partner can also exert a considerable influence on these patients. Aline Pelle investigated patients with a so-called type D personality. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Psychology / Psychiatry Source Type: news
Results From Two Phase II Trials Add To Understanding Of Ticagrelor (BRILINTA(TM)) And How It Works In The BodyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AstraZeneca (NYSE: AZN) announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,(1,2) with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.(3) The ONSET/OFFSET data showed that treatment with ticagrelor (BRILINTA(TM)) achieved a more rapid onset of antiplatelet effect (41% IPA vs. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Levels Of Bad Cholesterol Falling In US, But Still Too Many Unscreened And UntreatedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new study published this week found that the proportion of American adults with high levels of low-density lipoprotein (LDL or "bad") cholesterol fell by around one third between 1999 and 2006, but concluded that too many are still not being screened or treated for the condition. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cholesterol Source Type: news
Crestor® Reduced Risk Of Cardiovascular Events In Women By Nearly Half In New Analysis Of Jupiter StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new analysis of 6,801 women in the JUPITER study showed CRESTOR® (rosuvastatin calcium) 20 mg significantly reduced cardiovascular (CV) events (defined as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by nearly half (46 percent; p=0.002 vs. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Aldagen Announces Clinical Data For ALD-201 For Ischemic Heart Failure Presented At AHAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Aldagen, Inc. announced that results from a Phase 1 clinical trial of ALD-201, a cell therapy being developed as a treatment for ischemic heart failure, were presented at AHA. In the study, ALD-201 was found to be well-tolerated and to improve myocardial perfusion. The data were presented at the American Heart Association Scientific Sessions 2009 by Emerson C. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Hospital Report Cards Do Not Appear To Result In Significant ImprovementsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An analysis of quality of cardiac care following the public release of data on measures of care at hospitals in Ontario, Canada, did not result in significant systemwide improvement in hospitals' performance on most quality of care indicators, according to a study to be published in the December 2 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
ED Drug Improves Heart's Pumping Action In Young Patients With Single-Ventricle DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia. Single-ventricle defects are a collection of cardiac malformations that impair the heart's ability to pump blood. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Vitamin B Niacin Offers No Additional Benefit To Statin Therapy In Seniors Already Diagnosed With Coronary Artery DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Statins Source Type: news
Pluristem Therapeutics Announces Three Month Follow-Up Data From The First Patient To Receive PLX-PADEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) announced that safety and potential efficacy parameters were demonstrated by the three month follow up data from the first patient ever to receive its placenta derived cell therapy product, PLX-PAD. The patient is participating in a Phase I dose-escalating clinical trial in Europe with PLX-PAD, the company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD). (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
NIH Awards $8.5 Million For Research On Pharmaceuticals For ChildrenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Studying drugs in pediatric populations is challenging because drugs often affect children differently than they do adults. The scarcity of pediatric studies limits the ability of doctors and scientists to predict drug dosing, safety and efficacy in children. To address this gap, the National Institutes of Health has announced 18 grants to help determine outcome measures and increase the likelihood of success of future trials of treatments for children. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Pediatrics / Children's Health Source Type: news
Highlights Of NHLBI-Supported Research Presented At American Heart Association's Scientific SessionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Results From Phase 2b Study On Atrial Fibrillation Agent Reviewed At American Heart AssociationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 19, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
OmniComm's TrialMasterTM EDC Solution Selected By Leading Medical Device Manufacturer For Phase IV Cardiovascular Device StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that a leader in the medical device industry has selected OmniComm's TrialMaster EDC solution for the data capture of a Phase IV cardiovascular study. The 24-month, 7-site study will enroll 100 subjects. "We look forward to continuing our successful collaboration with this device company," remarked Stephen Johnson, COO of OmniComm Systems. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Medical Devices / Diagnostics Source Type: news
Newer Heart Devices Significantly Improve Survival, Complication Rate And Quality Of LifeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate permanent therapy for many of the more than 5 million Americans who suffer from heart failure. A research team led by a University of Louisville cardiac surgeon published data to support these conclusions in the November 17, 2009 Online First edition of the New England Journal of Medicine. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Heart Failure Patients With Kidney Dysfunction Don't Recover Well After Hospital DischargeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Most heart failure patients who develop kidney failure in the hospital do not recover from it before going home and are at increased risk of either being re-hospitalized or dying within the year, according to a Henry Ford Hospital study. The study's gloomy finding is the first time researchers linked long-term health outcomes with declining kidney function in patients hospitalized for heart failure. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
For Diabetic Patients With Heart Disease, Drug Therapy More Cost-Effective Than AngioplastyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. Previous research had shown that patients with type-2 diabetes and mild-to-moderate heart disease have no reduction in risk for heart attacks, strokes or death if they have an angioplasty compared with simply taking the right medications. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Heart Failure Patients' Salt Consumption Lowered By Family Partnership, Education InterventionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Educating family members of heart failure (HF) patients about the health benefits of consuming a low-salt diet and providing skills for support and communication can effectively reduce HF patients' sodium consumption, according to an interdisciplinary study led by Emory University cardiovascular nursing researcher Sandra Dunbar, RN, DSN, FAAN, FAHA. Dunbar presented key findings of this study at the annual meeting of the American Heart Association in Orlando. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Global Alliance For Chronic Diseases Announces TargetsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Egyptian Mummies Reveal Heart Disease As Ancient AfflictionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new study finds that atherosclerosis, hardening of the arteries, was common in ancient Egyptians, challenging a belief that vascular disease is a modern affliction caused by current-day risk factors such as stress and sedentary lifestyles. Michael Miyamoto, MD, a graduate of the UC San Diego School of Medicine and assistant clinical professor, recently returned to the US following an expedition to Egypt to evaluate the prevalence of cardiovascular disease in 3,500-year-old mummies. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Researchers Discover Heart Disease In 3,500-Year-Old MummiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Hardening of the arteries has been detected in 3,500-year-old mummies, so we may have to look beyond modern risk factors to fully understand heart disease, according to research presented American Heart Association's Scientific Sessions 2009. Although atherosclerotic cardiovascular disease is commonly ascribed to modern risk factors, this study found evidence of the disease which causes heart attacks and strokes in ancient Egyptian mummies. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
American Heart Association Late-Breaking Clinical Trial Report: Tailoring Drug Dose To Heart Failure Patients' Response More EffectiveEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tailoring the dose of a heart failure drug to a patient's response is better than the one-size-fits-all approach, according to research presented in a late-breaking clinical trial at the American Heart Association's Scientific Sessions 2009. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
American Heart Association Late Breaking Clinical Trial Report: High Dose Of Angiotensin Receptor Blockers Effective In Heart Failure PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A larger dose of angiotensin receptor blockers (ARBs) is more effective than a smaller dose in heart failure patients, researchers said at the American Heart Association's Scientific Sessions 2009. The Comparison of Low-Dose vs. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Scans Of Egyptian Mummies Show Hardening Of Arteries Is Not A Modern DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An international team of scientists who took CT scans of mummified bodies of people who lived in Egypt up to 3,500 years ago found evidence to suggest that hardening of arteries, a risk factor for heart attacks and strokes, is not a modern disease and may have been quite common among ancient Egyptians of high socioeconomic status. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Poniard Pharmaceuticals Announces Updated Positive Clinical Data From Phase 2 Trial Of Picoplatin In Colorectal CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Colorectal Cancer Source Type: news
LA Biomed Study Finds Medication Improves Health Of Patients With Pulmonary Arterial HypertensionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Inhibition Of GRK2 Is Protective Against Acute Cardiac Stress InjuriesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Translational Medicine at Thomas Jefferson University. The studies will be presented at the American Heart Association Scientific Sessions 2009 in Orlando, Fla. The first study was presented by Henriette Brinks, M.D. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
$100 Million NHLBI 'Bench To Bassinet' Effort In Congenital Heart DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease. The Pitt team, led by Cecilia Lo, Ph.D. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Health Insurance / Medical Insurance Source Type: news
Stem Cells Improve Heart Function In Patients With CardiomyopathyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A Florida cardiologist is using stem cell therapy to treat patients who suffer from a range of heart, lung and vascular illnesses. The results have been extraordinary. Zannos Grekos, M.D. uses the patients' own stem cells to treat the diseases. "One's own stem cells offer great potential for the treatment of serious heart, lung and vascular diseases," Dr. Grekos said. "We are seeing remarkable outcomes through this treatment. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Stem Cell Research Source Type: news
Merck Announces Completion Of Patient Enrollment In Phase III Trial Of SCH 530348, A Novel, Oral Antiplatelet PAR-1 InhibitorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merck announced the completion of patient enrollment in the TRA 2°P-TIMI 50 clinical trial, a Phase III, randomized, double-blind, placebo-controlled, multinational study of SCH 530348, the company's investigational antiplatelet protease activated receptor-1 (PAR-1) inhibitor. The study, conducted by the Thrombolysis in Myocardial Infarction (TIMI) Study Group, reached its target of more than 26,000 patients. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Abbott Announces Positive Three-Year Data On Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced three-year data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries. Patients in this first phase of the ABSORB trial experienced no stent thrombosis (blood clots) out to three years and no new major adverse cardiac events (MACE1) between six months and three years (3. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Women Suffering Sudden Cardiac Arrest Have Lower Prevalence Of Structural Heart Disease Compared To MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A woman who suffers sudden cardiac arrest is significantly less likely than a man to exhibit the decrease in the heart's pumping ability that is widely recognized as a precursor, says a new study in the Nov. 24 Journal of the American College of Cardiology. The lack of left ventricular dysfunction could mean that fewer women meet current medical guidelines for implantable cardiac defibrillators that can prevent sudden cardiac arrest, says the study's lead researcher. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Telephone-Delivered Care For Treating Depression After CABG Surgery Appears To Improve OutcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Patients At UCSD Hospital Three Times More Likely To Survive Cardiac Arrest With New Advanced Resuscitation Training ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZOLL Medical Corporation (NasdaqGS: ZOLL) announced that in a "Best of the Best" presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest. Dr. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Healthy Older Adults Not At Risk From Exercise-Linked Ventricular TachycardiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Healthy, older adults free of heart disease need not fear that bouts of rapid, irregular heartbeats brought on by vigorous exercise might increase short- or long-term risk of dying or having a heart attack, according to a report by heart experts at Johns Hopkins and the U.S. National Institute on Aging (NIA). (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Aterovax's SPLA2 Activity Test Significantly Improves Prediction Of Cardiovascular Events In Large Prospective StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease (CAD) over a 5 year period, independent of established risk markers, including C-reactive protein. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Key Omega-3 Fatty Acid Increased By Oil From Biotech SoybeansEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Oil from soybeans modified through biotechnology increased levels of omega-3 eicosapentaenoic acid (EPA) in red blood cells according to research presented at the American Heart Association's Scientific Sessions 2009. "This soybean oil could be an effective alternative to fish oil as a source of heart-healthy omega-3 fatty acids," said William Harris, Ph.D. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Early Cooling In Cardiac Arrest May Improve SurvivalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Rapidly cooling a person in cardiac arrest may improve their chance of survival without brain damage, according to research presented at the American Heart Association's Scientific Sessions 2009. "We now have a method that is safe and can be started within minutes of cardiac arrest to minimize damage during this very critical period," said Maaret Castrén, M.D., lead author of the study and professor of emergency medicine at the Karolinska Institute in Stockholm. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Comparing Two Surgical Strategies For Infant Heart DefectEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Infants born with a severely underdeveloped heart are more likely to survive to their first birthday when treated with a new shunt procedure - yet it may not be the safest surgery long term, according to research presented at the American Heart Association's Scientific Sessions 2009. Babies born with a critically underdeveloped left side of their hearts require three surgeries to correct the problem. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Analysis Shows Bystanders Can Save More Lives When Doing Chest Compressions Only Instead Of Mouth-To-mouth CPREmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The chance of surviving a cardiac arrest outside a hospital was found to be twice as high when bystanders performed continuous chest compressions without mouth-to-mouth breathing than when bystanders performed standard CPR. These are the latest findings reported by the Resuscitation Research Group at the University of Arizona Sarver Heart Center and the SHARE Program (Save Hearts in Arizona Research and Education) at the Arizona Department of Health Services. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Post-Discharge, Elevated Biomarkers Lead To Diminished Quality Of Life In Heart Attack PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. The study examined a subset of patients in a 4,500-patient heart attack registry from 24 24 U.S. hospitals and found: 9 percent had elevated levels of the biomarker troponin (TnT) after six months. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Scientific Meeting On Latest Breakthroughs And Techniques For Improving Success Rate Of Chronic Total OcclusionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHAT: The Seventh International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
